Syros Pharmaceuticals, Inc.
SYRSDelisted Mar 10, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001556263
Syros Pharmaceuticals, Inc. was delisted on Mar 10, 2025; its insiders filed their last Form 4 on Dec 4, 2024; 44 institutions reported holding it in 13F filings for Q4 2024, worth $1.20M in total; no superinvestor held it.
Q2 2023 vs. Q1 2023
How the institutions holding Syros Pharmaceuticals, Inc. changed between Q1 2023 and Q2 2023.
All holders in Q2 2023All holders in Q1 2023
| Measure | Q1 2023 | Q2 2023 | Change |
|---|---|---|---|
| Holders | 59 | 53 | −6 |
| Shares | 10.3M | 10.6M | +321.8K (+3.1%) |
| Value | $27.5M | $33.5M | +$5.96M (+21.7%) |
New holders (4)
Institutions that held Syros Pharmaceuticals, Inc. at the end of Q2 2023 but not at the end of Q1 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Knott David M Jr | 96,260 | $303.0K | 0.13% |
| First Capital Advisors Group, LLC. | 1,123 | $3.54K | 0.00% |
| Rhumbline Advisers | 659 | $2.08K | 0.00% |
| FMR LLC | 97 | $306 | 0.00% |
Sold out (10)
Institutions that held Syros Pharmaceuticals, Inc. at the end of Q1 2023 and filed for Q2 2023 without it.
| Institution | Shares, Q1 2023 | Value, Q1 2023 |
|---|---|---|
| Ally Bridge Group (NY) LLC | 249,126 | $665.2K |
| Marshall Wace, LLP | 30,551 | $81.6K |
| Susquehanna International Group, LLP | 19,633 | $52.4K |
| Clarius Group, LLC | 18,620 | $49.7K |
| Prelude Capital Management, LLC | 14,899 | $39.8K |
| Acadian Asset Management LLC | 12,776 | $34.0K |
| Tower Research Capital LLC (TRC) | 6,584 | $18.0K |
| Ten Capital Wealth Advisors, LLC | 219 | $585 |
| GWM Advisors LLC | 15 | $40 |
| Simplex Trading, LLC | 196 | $0 |